見出し hamburger arrow home scrollable_table
Early cancer detection
UDX HIRAHATA CLINIC  >  Early cancer detection  >  What is oncogene diagnosis?

What is oncogene diagnosis?

Our gene-level diagnostic techniques allow us to find cancer in the earliest stages,earlier than it is possible with cytoscopy.
Cancer cells develop due to genetic mutations.
We no longer need to wait for cancer cells to multiply and grow in order to detect the disease. We can now detect cancer based on the accumulation of genetic mutations at the earliest stages, and begin delivering treatment earlier as a result.

Our Genetic Cancer Diagnostics

Our clinic’s genetic cancer diagnostic works by looking into the accumulation of genetic mutations.
By drawing a mere 28ml blood sample, we can investigate the chances that your genes harbor cancer.
If that is the case, we will be able to perform further tests to locate the cancer within your body as well as offering an estimate of a patient’s risk of developing different cancers for a period of 3-5 years following the test.

名称未設定-1

Features of our “Cancer Screening” and “Genetic Cancer Diagnostics”

For our Cancer Screening, we conduct methylation analysis on the length and concentration of the DNA strands which make up your genes, allowing us to evaluate your risk for cancer at an earlier stage than screening more commonly available.
A screening which turns up anomalous results across two or more our database’s diagnostic criteria can be considered as signifying cancer with more than 95% certainty.

In addition to Cancer Screening described above, our Genetic Cancer Diagnostics investigates a full spread of 131 different types of genetic mutations, including sudden genetic mutations of genes associated with cancer and others.
Because of this, we are able to investigate what kind of cancer has what chance of developing, and which part of the body it is likely to develop in, and whether or not a patient is at high risk of having already developed cancer.
Furthermore, we use this diagnostic to gather personalized data regarding Anti-Cancer Genetic Therapy for each individual patient.